Ebola
GSK launches Ebola Phase III trial in Liberia
January 23, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink
A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
Interview: Rajeev Venkayya, president of Takeda Vaccine
January 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bush, Ebola, Gates, Rajeev Venkayya, Takeda, brett wells, vaccines
Rajeev Venkayya is the president of the global vaccine business unit at Takeda Pharmaceuticals. He has served as special assistant …
UK nurse with Ebola in ‘critical condition’
January 6, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp
A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …
New hope through Ebola vaccine trial
December 23, 2014Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda
A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …
Government plans £6 billion precision medicine strategy
December 18, 2014Research and Development, Sales and Marketing ABPI, Cell Therapy Catapult, Ebola, George Osborne, UK, government
The government has committed to a £6 billion investment in scientific research and development as part of its science and …
GSK Ebola vaccine gets EU support
December 17, 2014Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson
A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
Merck Ebola vaccine shows promise
December 4, 2014Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics
Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
Takeda: we’re working on Ebola too
November 24, 2014Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya
The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …
Sanofi appoints an Ebola response co-ordinator
November 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ebola, Sanofi, gary nobel
Former director of the NIH Vaccine Research Center Dr Gary Nabel has been hired by Sanofi to spearhead its contribution …
MSF starts trials of Ebola candidates
November 14, 2014Research and Development, Sales and Marketing Ebola, MSF, Médecins Sans Frontières, avigan, brincidofovir, favipiravir
Three experimental Ebola therapies will be tested at sites operated by Médecins Sans Frontières (MSF) in West Africa, according to …
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
J&J announces ‘major commitment’ to Ebola effort
October 22, 2014Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid
Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …
GSK: Ebola vaccines will come ‘too late’
October 17, 2014Manufacturing and Production, Research and Development, Sales and Marketing Ebola, GSK, JK-05, Sihuan, tekmira, vaccines, zmapp
GlaxoSmithKline says its potential Ebola vaccine will come ‘too late’ for the current outbreak despite being fast-tracked. In August the …
Chinese military-linked firm says it has Ebola cure
October 14, 2014Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp
A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …
Latest content
